Function-Oriented Studies Targeting Pectenotoxin 2: Synthesis of the GH-Ring System and a Structurally Simplified...

Area of Science:

• Marine natural products chemistry
• Medicinal chemistry
• Chemical biology

Background:

• Pectenotoxin 2 (PTX2) is a marine toxin with demonstrated anticancer properties.
• The molecular mechanisms underlying PTX2's biological activity, particularly its anticancer effects, remain incompletely understood.
• Identifying key structural features responsible for PTX2's bioactivity is crucial for developing novel therapeutic agents.

Purpose of the Study:

• To establish a chemical foundation for function-oriented studies of pectenotoxin 2 (PTX2).
• To synthesize a PTX2 analogue lacking the AB-spiroketal moiety, hypothesized to be the "Achilles' heel" for its anticancer activity.
• To investigate the role of the AB-spiroketal and other structural features in PTX2's anticancer properties.

Main Methods:

• Synthesis of the bicyclic GH-system, a core structural component of PTX2.
• Design and chemical synthesis of a novel PTX2 analogue.
• Comparative biological evaluation of the PTX2 analogue and the natural product for anticancer activity.

Main Results:

• Successful synthesis of the bicyclic GH-system and a PTX2 analogue was achieved.
• The synthesized PTX2 analogue, while retaining actin-binding features, lacked the AB-spiroketal.
• The PTX2 analogue did not exhibit the anticancer properties observed for the natural product PTX2.

Conclusions:

• The absence of anticancer activity in the PTX2 analogue suggests the AB-spiroketal is not solely responsible for this effect.
• The results indicate that structural features within the CDEF-tetracycle of PTX2 are critical for its anticancer properties.
• This study provides valuable insights into the structure-activity relationships of PTX2, guiding future drug design efforts.